A “low-normal” iron level on your annual labs is now a marketing opportunity. So is borderline vitamin D, slightly suboptimal B12, or any number of metrics within normal range that wellness culture has redefined as deficiencies in waiting. The blood test is treated as the moment of truth. The supplement is the obvious response.
That logic falls apart on closer examination. Lab values are noisier than people think, normal ranges are wider than supplement marketing implies, and intervening on small deviations often produces no benefit and sometimes real harm.
Reference ranges are statistical, not clinical
A “normal” range on a lab report is typically defined as the central 95% of values in a healthy reference population. By construction, 5% of healthy people fall outside that range, and being slightly low or slightly high inside it carries no automatic clinical meaning. Many values also fluctuate substantially day to day, with the time of day, recent meals, hydration, and stress. A vitamin D level of 32 ng/mL one morning might be 28 the next without anything having changed in your body. Treating a single number near a boundary as a deficiency to be corrected reflects a misunderstanding of what the number is. Doctors trained in evidence-based medicine know this. Supplement marketing depends on you not.
Most supplementation in non-deficient people doesn’t help
Large clinical trials on multivitamins, vitamin D, fish oil, and most popular supplements have repeatedly failed to find meaningful benefits in people who are not actually deficient. The VITAL trial on vitamin D and omega-3s, the Physicians’ Health Study on multivitamins, and numerous others show small or null effects on the outcomes the supplements are supposed to influence — cardiovascular events, cancer, fractures, mood. The story changes for people with documented deficiencies and specific medical conditions, where targeted supplementation does help. But that’s the point: the evidence supports treating real deficiencies, not topping up borderline values to feel optimized. The latter is mostly placebo, expensively packaged.
Some supplements at high doses cause real harm
The “more is better” framing imported from pharmaceuticals doesn’t apply to most nutrients, and ignoring this gets people hurt. Excess vitamin A can damage the liver and cause birth defects. High-dose vitamin E has been linked to increased mortality. Iron supplementation in non-deficient people increases oxidative stress and may worsen cardiovascular outcomes. Calcium supplements in older adults have been associated with kidney stones and possibly cardiac events. The supplement industry routinely sells doses that exceed any plausible therapeutic need, marketed as “high potency” rather than what they often are — past the point of benefit and into the range of harm. A lab value that doesn’t actually require correction is not a reason to take that risk.
The bottom line
Lab tests are useful when interpreted by clinicians in clinical context. They are not coupons for the supplement aisle. If your labs come back reassuringly normal, the most evidence-based move is usually to do nothing and check again next year. The pills marketed against your numbers are not, in most cases, the medicine they pretend to be.
Leave a Reply